Toronto-based Bionik Laboratories Corp announces its financial results for 2015 and its business outlook for 2016.
A media release from the company reports that, for the year ended December 31, 2015, the Company reported a comprehensive loss of $5,569,107 resulting in a loss per share of $(0.08) compared to a comprehensive loss of $2,489,137 for the year ended December 31, 2014, resulting in a loss per share of $(0.05). The Company ended the year with $6,617,082 of cash and cash equivalents and working capital of $890,885. Excluding the non-cash warrant derivate liability, working capital would be $6,958,754.
Also in 2015, the company announced a merger agreement to acquire Boston-based rehabilitation robot manufacturer Interactive Motion Technologies Inc. As well, it re-engineered the ARKE exoskeleton for a lighter mechanical profile and improved control, adaptability, safety, and electronics; and began production on its ARKE GEN2 exoskeleton, per the release.
For more information, visit Bionik Laboratories Corp.
[Sourcer(s): Bionik Laboratories Corp, PR Newswire]
